Treatment of human induced pluripotent stem (iPS) cell-derived macrophage precursor cells (MPCs) 35 with erucamide led to significantly higher levels of PDGF, VEGF, FGF-2, IGF-1 and BDNF compared to controls (Fig
In the AMPLITUDE-O post-hoc analysis, the HR for MACE was 0.70 (95% CI 0.371.30) with baseline SGLT2is and 0.74 (95% CI 0.580.94) without SGLT2is ( P -value for interaction 0.70), and the HR for HHF was 0.23 (95% CI 0.050.97) with SGLT2is and 0.70 (95% CI 0.421.17) without SGLT2is ( P -value for interaction 0.35) [47]
Le Glow Blend This is a synergistic 3-in-1 formulation co-formulated by French Peptides, combining: GHK-Cu (collagen synthesis, matrix remodeling), BPC-157 (angiogenesis via VEGF/eNOS, formation of new dermal capillaries), and TB-500 (actin regulation, keratinocyte and fibroblast migration, fibrosis reduction)
This active model predicts and coherently explains all data examined, which included stress, sleep, caloric restriction, stroke, type 1 diabetes mellitus, obesity, and type 2 diabetes
